Graves, L., Rupprecht, G., Altunel, E., Flamant, E. M., Rao, S., Sivara, D., … Somarelli, J. A. (2022). Exportin 1 (XPO1) inhibition alone or in combination as a novel therapeutic strategy in osteosarcoma. In CANCER RESEARCH (Vol. 82).

Graves, Laurie, Gabrielle Rupprecht, Erdem Altunel, Etienne M. Flamant, Sneha Rao, Dharshan Sivara, Alexander L. Lazarides, et al. “Exportin 1 (XPO1) inhibition alone or in combination as a novel therapeutic strategy in osteosarcoma.” In CANCER RESEARCH, Vol. 82, 2022.

Graves L, Rupprecht G, Altunel E, Flamant EM, Rao S, Sivara D, et al. Exportin 1 (XPO1) inhibition alone or in combination as a novel therapeutic strategy in osteosarcoma. In: CANCER RESEARCH. 2022.

Graves, Laurie, et al. “Exportin 1 (XPO1) inhibition alone or in combination as a novel therapeutic strategy in osteosarcoma.” CANCER RESEARCH, vol. 82, no. 12, 2022.

Graves L, Rupprecht G, Altunel E, Flamant EM, Rao S, Sivara D, Lazarides AL, Hoskinson SM, Sheth MU, Cheng S, Kim SY, Ware KE, Agarwal A, Cullen MM, Syal C, Selmic LE, Everitt JI, McCall SJ, Eward C, Kashyap T, Maloof M, Walker CJ, Landesman Y, Wagner L, Eward WC, Hsu DS, Somarelli JA. Exportin 1 (XPO1) inhibition alone or in combination as a novel therapeutic strategy in osteosarcoma. CANCER RESEARCH. 2022.